Ricoh Biosciences
Ricoh Biosciences enables Alzheimer’s R&D teams to de-risk decisions earlier with a human-relevant, ISO 9001:2015-certified iPSC platform. Our patient-derived AD panel combines broad genetic diversity with validated biomarker readouts (Aβ42, pTau, total Tau) and a rapid turnaround—helping prioritize assets, strengthen translational confidence, and accelerate the path to the clinic.
